CD7 is a transmembrane glycoprotein of the immunoglobulin superfamily that is expressed in a high proportion of T-ALL and T-cell lymphomas.88 Lu et al reported an open, single-arm phase I clinical trial of naturally selected CD7 CAR-T (NS7CAR). Here, CD7 is linked to T-cell non-Hodgkin lymphoma.